Stocks
Intra-Cellular Therapies (ITCI) P/E US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -9.86 | -15.0 | 0.00 | 0.00 | -115.3 | -182.1 | ||
| Changes by years, y/y, % | -23% | +52% | -100% | +55.2% | |||||
Intra-Cellular Therapies. P/E
Intra-Cellular Therapies. P/E, changes, %
Intra-Cellular Therapies (ITCI) P/E US GAAP (quarter values) |
||||||||
| FY2023Q4 | FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | LTM ? | |||
| P/E | ? | 0.00 | 0.00 | 0.00 | -89.6 | -115.3 | -182.1 | |
| Changes by years, y/y, % | -100% | -100% | ||||||
| Changes by quarters, q/q, % | +29% | |||||||
